China FDA Launches Major Enforcement Campaign; Official Cautions Rainy Days Ahead
This article was originally published in The Pink Sheet Daily
Executive Summary
If a widening anti-bribery investigation, a new drug cost survey and looming pricing reform is not enough, China FDA just launched its first major campaign to root out violations in pharmaceutical manufacturing and distribution. Industry needs to get ready for rainy days, an official cautioned.